Freitag P, Jandová A, Macků J, Bendová M, Nedbalová M
II. gynek.-porod. klinika, 1. LF UK, Praha.
Ceska Gynekol. 1994 Oct;59(5):264-7.
The cell mediated immunity was examined by the leukocyte adherence inhibition (LAI) test in 21 patients with CIN III and 146 patients with invasive gynaecologic malignancies before treatment and at 3-month intervals. Our own LDV antigen and organ specific antigens were used. The test was highly specific (95.1%) in comparison with a control group of healthy blood donors. The sensitivity of the test was lower (64.7-86.8%). There was no correlation with the development of disease (remission or relapse). The test in a two-year investigation does not seem suitable for monitoring of disease. Depending the nature of LDV infection, only a longer investigation extending over more years would enable further conclusions.
采用白细胞黏附抑制（LAI）试验，对21例CIN III患者和146例浸润性妇科恶性肿瘤患者在治疗前及每隔3个月进行细胞介导免疫检测。使用我们自己的LDV抗原和器官特异性抗原。与健康献血者对照组相比，该试验具有高度特异性（95.1%）。试验的敏感性较低（64.7 - 86.8%）。与疾病的发展（缓解或复发）无关。在一项为期两年的调查中，该试验似乎不适合用于疾病监测。根据LDV感染的性质，只有进行更长时间、持续多年的调查才能得出进一步结论。
